# Lonza

global GMP capacity (Lonza Visp/US, Catalent, Thermo Fisher Patheon) that lets a sponsor manufacture in-region without owning a plant.

Source: https://en.bioecon.ru/companies/lonza/
Updated: 2026-06-24

- Country: Switzerland

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | CHF 6.5 billion for FY 2025 | https://www.lonza.com/news/2026-01-28-06-30 |
| Capacity | total bioreactor capacity of around 332,000 liters (including Vacaville site) | https://www.lonza.com/-/media/Lonza/Lonzacom/investor-relations/Financial%20Presentations/20260113_Lonza_JPM_2026_Presentation_Final, https://www.pharmamanufacturing.com/sector/contract-manufacturing/article/55338889/lonzas-available-us-capacity-global-footprint-are-major-competitive-advantages-analysts |
| Capacity | single-use bioreactor technologies up to 2,000L and stainless-steel bioreactors from 6,000L to 25,000L | https://www.lonza.com/integrated-biologics/manufacturing, https://www.lonza.com/integrated-biologics/manufacturing/mammalian-drug-manufacturing |
| Certification | cGMP-compliant facilities | https://www.lonza.com/integrated-biologics/manufacturing, https://www.lonza.com/integrated-biologics/manufacturing/mammalian-drug-manufacturing |
| Regulatory approval | 80+ successful site inspections by 14 global health authorities (including FDA and EMA) in last 5+ years | https://www.lonza.com/integrated-biologics/manufacturing, https://www.lonza.com/integrated-biologics/manufacturing/mammalian-drug-manufacturing |
| Production site | 6-7 cGMP manufacturing sites globally (across three continents) | https://www.lonza.com/integrated-biologics/manufacturing/mammalian-drug-manufacturing |
| Headcount | 20,000 colleagues | https://www.lonza.com/ |
| Headquarters | Basel, Switzerland | https://www.lonza.com/-/media/Lonza/Lonzacom/investor-relations/Financial%20Presentations/20260113_Lonza_JPM_2026_Presentation_Final |

Independent sources: pharmamanufacturing.com

## Technologies

- [Bioproduction CDMO/CMO (biologics/ATMP/mRNA)](https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/)
- [Chemoenzymatic API synthesis (biocatalytic small-molecule manufacturing)](https://en.bioecon.ru/technology/chemoenzymatic-api-synthesis/)
- [Endotoxin testing systems](https://en.bioecon.ru/technology/endotoxin-testing-systems/)
- [Local manufacturing for market access](https://en.bioecon.ru/technology/local-manufacturing-for-market-access/)
- [Media manufacturing (B2B production equipment)](https://en.bioecon.ru/technology/media-manufacturing-equipment/)
- [Microcarriers for adherent cell cultures](https://en.bioecon.ru/technology/microcarriers-adherent-cell-culture/)